Rein Therapeutics, Inc. · NASDAQ:RNTX

Lynwood Capital Management Inc. reported a 6.10% stake in Rein Therapeutics, Inc. (Schedule 13G)

Event May 4, 2026 · Filed May 8, 2026

Lynwood Capital Management Inc. reported a 6.10% stake in Rein Therapeutics, Inc., 4,750,000 shares, as a passive investor on May 4, 2026. Filed May 8, 2026 (Schedule 13G).

Stake
6.10%
Shares
4,750,000
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Lynwood Capital Management Inc.6.10%4,750,000
Benjamin Shapiro6.10%4,750,000
Lynwood Opportunities Master Fund6.10%4,750,000

Source

View original at SEC

Related